Spironolactone Plus Full-Dose ACE Inhibition in Patients with Idiopathic Membranous Nephropathy and Nephrotic Syndrome: Does It Really Work?

Author: Cravedi Paolo   Brusegan Varusca   Ruggenenti Piero   Campbell Ruth   Remuzzi Giuseppe  

Publisher: MDPI

E-ISSN: 1424-8247|3|1|1-9

ISSN: 1424-8247

Source: Pharmaceuticals, Vol.3, Iss.1, 2010-01, pp. : 1-9

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content